Cargando…

Inclusion and definition of acute renal dysfunction in critically ill patients in randomized controlled trials: a systematic review

BACKGROUND: In evidence-based medicine, multicenter, prospective, randomized controlled trials (RCTs) are the gold standard for evaluating treatment benefits and ensuring the effectiveness of interventions. Patient-centered outcomes, such as mortality, are most often the preferred evaluated outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: da Hora Passos, Rogerio, Ramos, Joao Gabriel Rosa, Gobatto, André, Caldas, Juliana, Macedo, Etienne, Batista, Paulo Benigno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979001/
https://www.ncbi.nlm.nih.gov/pubmed/29690893
http://dx.doi.org/10.1186/s13054-018-2009-x
_version_ 1783327599886336000
author da Hora Passos, Rogerio
Ramos, Joao Gabriel Rosa
Gobatto, André
Caldas, Juliana
Macedo, Etienne
Batista, Paulo Benigno
author_facet da Hora Passos, Rogerio
Ramos, Joao Gabriel Rosa
Gobatto, André
Caldas, Juliana
Macedo, Etienne
Batista, Paulo Benigno
author_sort da Hora Passos, Rogerio
collection PubMed
description BACKGROUND: In evidence-based medicine, multicenter, prospective, randomized controlled trials (RCTs) are the gold standard for evaluating treatment benefits and ensuring the effectiveness of interventions. Patient-centered outcomes, such as mortality, are most often the preferred evaluated outcomes. While there is currently agreement on how to classify renal dysfunction in critically ill patients , the application frequency of this new classification system in RCTs has not previously been evaluated. In this study, we aim to assess the definition of renal dysfunction in multicenter RCTs involving critically ill patients that included mortality as a primary endpoint. METHODS: A comprehensive search was conducted for publications reporting multicenter randomized controlled trials (RCTs) involving adult patients in intensive care units (ICUs) that included mortality as a primary outcome. MEDLINE and PUBMED were queried for relevant articles in core clinical journals published between May 2004 and December 2017. RESULTS: Of 418 articles reviewed, 46 multicenter RCTs with a primary endpoint related to mortality were included. Thirty-six (78.3%) of the trial reports provided information on renal function in the participants. Only seven articles (15.2%) included mean or median serum creatinine levels, mean creatinine clearance or estimated glomerular filtration rates. Sequential organ failure assessment (SOFA) score was the most commonly used definition of renal dysfunction (20 studies; 43.5%). Risk, Injury, Failure, Loss, End-stage renal disease (RIFLE), Acute Kidney Injury Network (AKIN) and Kidney Disease Improving Global Outcomes (KDIGO) criteria were used in five (10.9%) trials. In thirteen trials (28.3%), no renal dysfunction criteria were reported. Only one trial excluded patients with renal dysfunction, and it used urinary output or need for renal replacement therapy (RRT) as criteria for this diagnosis. CONCLUSION: The presence of renal dysfunction was included as a baseline patient characteristic in most RCTs. The RIFLE, AKIN and KDIGO classification systems were infrequently used; renal dysfunction was generally defined using the SOFA score.
format Online
Article
Text
id pubmed-5979001
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59790012018-06-06 Inclusion and definition of acute renal dysfunction in critically ill patients in randomized controlled trials: a systematic review da Hora Passos, Rogerio Ramos, Joao Gabriel Rosa Gobatto, André Caldas, Juliana Macedo, Etienne Batista, Paulo Benigno Crit Care Research BACKGROUND: In evidence-based medicine, multicenter, prospective, randomized controlled trials (RCTs) are the gold standard for evaluating treatment benefits and ensuring the effectiveness of interventions. Patient-centered outcomes, such as mortality, are most often the preferred evaluated outcomes. While there is currently agreement on how to classify renal dysfunction in critically ill patients , the application frequency of this new classification system in RCTs has not previously been evaluated. In this study, we aim to assess the definition of renal dysfunction in multicenter RCTs involving critically ill patients that included mortality as a primary endpoint. METHODS: A comprehensive search was conducted for publications reporting multicenter randomized controlled trials (RCTs) involving adult patients in intensive care units (ICUs) that included mortality as a primary outcome. MEDLINE and PUBMED were queried for relevant articles in core clinical journals published between May 2004 and December 2017. RESULTS: Of 418 articles reviewed, 46 multicenter RCTs with a primary endpoint related to mortality were included. Thirty-six (78.3%) of the trial reports provided information on renal function in the participants. Only seven articles (15.2%) included mean or median serum creatinine levels, mean creatinine clearance or estimated glomerular filtration rates. Sequential organ failure assessment (SOFA) score was the most commonly used definition of renal dysfunction (20 studies; 43.5%). Risk, Injury, Failure, Loss, End-stage renal disease (RIFLE), Acute Kidney Injury Network (AKIN) and Kidney Disease Improving Global Outcomes (KDIGO) criteria were used in five (10.9%) trials. In thirteen trials (28.3%), no renal dysfunction criteria were reported. Only one trial excluded patients with renal dysfunction, and it used urinary output or need for renal replacement therapy (RRT) as criteria for this diagnosis. CONCLUSION: The presence of renal dysfunction was included as a baseline patient characteristic in most RCTs. The RIFLE, AKIN and KDIGO classification systems were infrequently used; renal dysfunction was generally defined using the SOFA score. BioMed Central 2018-04-24 /pmc/articles/PMC5979001/ /pubmed/29690893 http://dx.doi.org/10.1186/s13054-018-2009-x Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
da Hora Passos, Rogerio
Ramos, Joao Gabriel Rosa
Gobatto, André
Caldas, Juliana
Macedo, Etienne
Batista, Paulo Benigno
Inclusion and definition of acute renal dysfunction in critically ill patients in randomized controlled trials: a systematic review
title Inclusion and definition of acute renal dysfunction in critically ill patients in randomized controlled trials: a systematic review
title_full Inclusion and definition of acute renal dysfunction in critically ill patients in randomized controlled trials: a systematic review
title_fullStr Inclusion and definition of acute renal dysfunction in critically ill patients in randomized controlled trials: a systematic review
title_full_unstemmed Inclusion and definition of acute renal dysfunction in critically ill patients in randomized controlled trials: a systematic review
title_short Inclusion and definition of acute renal dysfunction in critically ill patients in randomized controlled trials: a systematic review
title_sort inclusion and definition of acute renal dysfunction in critically ill patients in randomized controlled trials: a systematic review
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979001/
https://www.ncbi.nlm.nih.gov/pubmed/29690893
http://dx.doi.org/10.1186/s13054-018-2009-x
work_keys_str_mv AT dahorapassosrogerio inclusionanddefinitionofacuterenaldysfunctionincriticallyillpatientsinrandomizedcontrolledtrialsasystematicreview
AT ramosjoaogabrielrosa inclusionanddefinitionofacuterenaldysfunctionincriticallyillpatientsinrandomizedcontrolledtrialsasystematicreview
AT gobattoandre inclusionanddefinitionofacuterenaldysfunctionincriticallyillpatientsinrandomizedcontrolledtrialsasystematicreview
AT caldasjuliana inclusionanddefinitionofacuterenaldysfunctionincriticallyillpatientsinrandomizedcontrolledtrialsasystematicreview
AT macedoetienne inclusionanddefinitionofacuterenaldysfunctionincriticallyillpatientsinrandomizedcontrolledtrialsasystematicreview
AT batistapaulobenigno inclusionanddefinitionofacuterenaldysfunctionincriticallyillpatientsinrandomizedcontrolledtrialsasystematicreview